Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases

Wiener Medizinische Wochenschrift

Volumn 158, Issue 19-20, 2008, Pages 542-548

  Trauner, Michael ^a   Fickert, Peter ^a   Halilbasic, Emina ^a   Moustafa, Tarek ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bile acids; Cholestasis; Phospholipids; Sclerosing cholangitis

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOLIPID; TRANSMEMBRANE CONDUCTANCE REGULATOR; URSODEOXYCHOLIC ACID;

BILE DUCT INJURY; BILE SECRETION; BILIARY CIRRHOSIS; CHOLELITHIASIS; CHOLESTASIS; CONFERENCE PAPER; DRUG EFFICACY; GENE MUTATION; INTRAHEPATIC CHOLESTASIS; LIVER CELL DAMAGE; LIVER FIBROSIS; NONHUMAN; PATHOGENESIS; SCLEROSING CHOLANGITIS;

ANIMALS; BILE; BILE ACIDS AND SALTS; BILE CANALICULI; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; CHOLESTASIS, INTRAHEPATIC; CHOLIC ACIDS; DISEASE MODELS, ANIMAL; HUMANS; LIVER NEOPLASMS; MICE; MICE, KNOCKOUT; MUTATION; NORSTEROIDS; P-GLYCOPROTEINS; URSODEOXYCHOLIC ACID;

EID: 55949085226     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-008-0592-1     Document Type: Conference Paper

References (55)

1. M Trauner JL Boyer 2003 Bile salt transporters: molecular characterization, function, and regulation Physiol Rev 83 633 671
2. RP Oude Elferink CC Paulusma 2007 Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein) Pflugers Arch 453 601 610
3. RP Oude Elferink CC Paulusma AK Groen 2006 Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases Gastroenterology 130 908 925
4. M Trauner P Fickert M Wagner 2007 MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes Semin Liver Dis 27 77 98
5. AF Hofmann 1995 Bile acids as drugs: principles, mechanisms of action and formulations Ital J Gastroenterol 27 106 113
6. AF Hofmann 1999 The continuing importance of bile acids in liver and intestinal disease Arch Intern Med 159 2647 2658
7. JJ Smit AH Schinkel RP Oude Elferink AK Groen E Wagenaar L van Deemter CA Mol R Ottenhoff NM van der Lugt MA van Roon 1993 Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease Cell 75 451 462
8. P Fickert A Fuchsbichler M Wagner G Zollner A Kaser H Tilg R Krause F Lammert C Langner K Zatloukal HU Marschall H Denk M Trauner 2004 Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 127 261 274
9. P Fickert G Zollner A Fuchsbichler C Stumptner AH Weiglein F Lammert HU Marschall O Tsybrovskyy K Zatloukal H Denk M Trauner 2002 Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles Gastroenterology 123 1238 1251
10. -/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes J Hepatol 43 1045 1054
11. TH Mauad CM van Nieuwkerk KP Dingemans JJ Smit AH Schinkel RG Notenboom MA van den Bergh Weerman RP Verkruisen AK Groen RP Oude Elferink 1994 Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis Am J Pathol 145 1237 1245
12. E Pikarsky RM Porat I Stein R Abramovitch S Amit S Kasem E Gutkovich-Pyest S Urieli-Shoval E Galun Y Ben-Neriah 2004 NF-κB functions as a tumour promoter in inflammation-associated cancer Nature 431 461 466
13. -/- mice: a model for low phospholipid-associated cholelithiasis Hepatology 39 117 128
14. M Katzenellenbogen L Mizrahi O Pappo N Klopstock D Olam J Jacob-Hirsch N Amariglio G Rechavi E Domany E Galun D Goldenberg 2007 Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice Mol Cancer Res 5 1159 1170
15. S Sheth JC Shea MD Bishop 2003 Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis Hum Genet 113 286 292
16. -/- mice results in bile duct injury Am J Physiol Gastrointest Liver Physiol 287 G491 G496
17. H Pall J Zielenski MM Jonas 2007 Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function J Pediatr 151 255 259
18. JM McGill DM Williams CM Hunt 1996 Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis Dig Dis Sci 41 540 542
19. E Girodon D Sternberg O Chazouilleres 2002 Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis J Hepatol 37 192 197
20. JF Gallegos-Orozco C EY N Wang 2005 Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis Am J Gastroenterol 100 874 878
21. KN Lazaridis M Strazzabosco NF LaRusso 2004 The cholangiopathies: disorders of biliary epithelia Gastroenterology 127 1565 1577
22. PR Durie G Kent MJ Phillips CA Ackerley 2004 Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model Am J Pathol 164 1481 1493
23. -/- mice J Pediatr Gastroenterol Nutr 42 275 281
24. -/- mice J Cell Physiol 200 235 244
25. P Fickert U Stöger A Fuchsbichler T Moustafa HU Marschall AH Weiglein O Tsybrovskyy H Jaeschke K Zatloukal H Denk M Trauner 2007 A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis Am J Pathol 171 525 536
26. ML Chang CT Yeh PY Chang JC Chen 2005 Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation World J Gastroenterol 11 4167 4172
27. P Fickert A Fuchsbichler HU Marschall M Wagner G Zollner R Krause K Zatloukal H Jaeschke H Denk M Trauner 2006 Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice Am J Pathol 168 410 422
28. PL Jansen E Sturm 2003 Genetic cholestasis, causes and consequences for hepatobiliary transport Liver Int 23 315 322
29. C Pauli-Magnus B Stieger Y Meier GA Kullak-Ublick PJ Meier 2005 Enterohepatic transport of bile salts and genetics of cholestasis J Hepatol 43 342 357
30. E Jacquemin JM De Vree D Cresteil EM Sokal E Sturm M Dumont GL Scheffer M Paul M Burdelski PJ Bosma O Bernard M Hadchouel RP Elferink 2001 The wide spectrum of multidrug resistance 3 deficiency: from neonatalcholestasis to cirrhosis of adulthood Gastroenterology 120 1448 1458
31. E Geuken D Visser F Kuipers H Blokzijl HG Leuvenink KP de Jong PM Peeters PL Jansen MJ Slooff AS Gouw RJ Porte 2004 Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation J Hepatol 41 1017 1025
32. +/- mice Hepatology 43 1022 1031
33. C Pauli-Magnus R Kerb K Fattinger T Lang B Anwald GA Kullak-Ublick U Beuers PJ Meier 2004 BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis Hepatology 39 779 791
34. E Melum KM Boberg A Franke A Bergquist J Hampe S Schreiber BA Lie E Schrumpf TH Karlsen 2007 Variation in the MDR3 gene influences disease progression in PSC patients and disease susceptibility in epistatic interaction with a polymorphism in the OST-alpha gene Hepatology 46 265A
35. J Prieto C Qian N Garcia J Diez JF Medina 1993 Abnormal expression of anion exchanger genes in primary biliary cirrhosis Gastroenterology 105 572 578
36. JF Medina A Martinez JJ Vazquez J Prieto 1997 Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis Hepatology 25 12 17
37. J Prieto N Garcia JM Marti-Climent I Penuelas JA Richter JF Medina 1999 Assessment of biliary bicarbonate secretion in humans by positron emission tomography Gastroenterology 117 167 172
38. - exchanger activities in primary biliary cirrhosis Hepatology 35 1513 1521
39. JJ Vazquez M Vazquez MA Idoate 1995 Anion exchanger immunoreactivity in human salivary glands in health and Sjogren's syndrome Am J Pathol 146 1422 1432
40. G Zollner P Fickert D Silbert 2003 Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis J Hepatol 38 717 727
41. C Spirli MH Nathanson R Fiorotto 2001 Proinflammatory cytokines inhibit secretion in rat bile duct epithelium Gastroenterology 121 156 169
42. NF LaRusso BL Shneider D Black GJ Gores SP James E Doo JH Hoofnagle 2006 Primary sclerosing cholangitis: summary of a workshop Hepatology 44 746 764
43. SN Cullen RW Chapman 2006 The medical management of primary sclerosing cholangitis Semin Liver Dis 26 52 61
44. U Beuers 2006 Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis Nat Clin Pract Gastroenterol Hepatol 3 318 328
45. G Paumgartner U Beuers 2004 Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease Clin Liver Dis 8 67 81
46. YB Yoon LR Hagey AF Hofmann D Gurantz EL Michelotti JH Steinbach 1986 Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents Gastroenterology 90 837 852
47. AF Hofmann SF Zakko M Lira C Clerici LR Hagey KK Lambert JH Steinbach CD Schteingart P Olinga GM Groothuis 2005 Novel biotransformation and physiological properties of norursodeoxycholic acid in humans Hepatology 42 1391 1398
48. P Fickert M Wagner HU Marschall A Fuchsbichler G Zollner O Tsybrovskyy K Zatloukal J Liu MP Waalkes C Cover H Denk AF Hofmann H Jaeschke M Trauner 2006 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 130 465 481
49. U Bolder NV Trang LR Hagey CD Schteingart HT Ton-Nu C Cerre RP Elferink AF Hofmann 1999 Sulindac is excreted into bile by a canalicular bile salt pump and undergoes acholehepatic circulation in rats Gastroenterology 117 962 971
50. M Leuschner J Holtmeier H Ackermann U Leuschner 2002 The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study Eur J Gastroenterol Hepatol 14 1369 1376
51. G Zollner HU Marschall M Wagner M Trauner 2006 Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations Mol Pharm 3 231 251
52. A Geier M Wagner CG Dietrich M Trauner 2007 Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration Biochim Biophys Acta 1773 283 308
53. M Wagner E Halilbasic HU Marschall G Zollner P Fickert C Langner K Zatloukal H Denk M Trauner 2005 CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice Hepatology 42 420 430
54. T Stojakovic C Putz-Bankuti G Fauler H Scharnagl M Wagner V Stadlbauer G Gurakuqi RE Stauber W März M Trauner 2007 Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid Hepatology 46 776 784
55. JT Salas JM Banales S Sarvide S Recalde A Ferrer I Uriarte RP Oude Elferink J Prieto JF Medina 2008 Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis Gastroenterology 134 5 1482 1493